Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Jukka P. Rissanen
Observed names:
J. P. Rissanen,
J.P. Rissanen,
Jukka P Rissanen,
Jukka Rissanen,
Rissanen, Jukka,
Rissanen, Jukka P
show all 6
Institution:
Pharmatest (Finland)
Observed institutions:
University of Helsinki,
University of Turku,
Pharmatest (Finland),
Raisio (Finland),
Institute for Molecular Medicine Finland,
Turku Centre for Biotechnology,
VTT Technical Research Centre of Finland
show all 7
OpenAlex ID:
A5061315354
Radium-223 Inhibits Osseous Prostate Cancer Growth by Dual Targeting of Cancer Cells and Bone Microenvironment in Mouse Models
2017
·
Mari I. Suominen
, Katja M. Fagerlund
, et al.
·
Clinical Cancer Research
·
186
Secreted Tartrate-Resistant Acid Phosphatase 5b is a Marker of Osteoclast Number in Human Osteoclast Cultures and the Rat Ovariectomy Model
2007
·
Jukka P. Rissanen
, Mari I. Suominen
, et al.
·
Calcified Tissue International
·
171
Survival Benefit With Radium-223 Dichloride in a Mouse Model of Breast Cancer Bone Metastasis
2013
·
Mari I. Suominen
, Jukka P. Rissanen
, et al.
·
JNCI Journal of the National Cancer Institute
·
95
PDF
Properties and expression of human tartrate-resistant acid phosphatase isoform 5a by monocyte-derived cells
2004
·
Anthony J Janckila
, Ranga N Parthasarathy
, et al.
·
Journal of Leukocyte Biology
·
68
Effects of Bioactive Peptide, Valyl-Prolyl-Proline (VPP), and Lactobacillus helveticus Fermented Milk Containing VPP on Bone Loss in Ovariectomized Rats
2007
·
Mirkka Narva
, Jukka Rissanen
, et al.
·
Annals of Nutrition and Metabolism
·
48
Heparin-like Polysaccharides Reduce Osteolytic Bone Destruction and Tumor Growth in a Mouse Model of Breast Cancer Bone Metastasis
2012
·
Sirkku Pollari
, Rami S. Käkönen
, et al.
·
Molecular Cancer Research
·
46
PDF
A unique anti-CD115 monoclonal antibody which inhibits osteolysis and skews human monocyte differentiation from M2-polarized macrophages toward dendritic cells
2013
·
Hélène Haegel
, Christine Thioudellet
, et al.
·
mAbs
·
42
PDF
Short-Term Changes in Serum PINP Predict Long-Term Changes in Trabecular Bone in the Rat Ovariectomy Model
2008
·
Jukka P. Rissanen
, Mari I. Suominen
, et al.
·
Calcified Tissue International
·
37
Improved methods for testing antiresorptive compounds in human osteoclast cultures
2008
·
Jukka P. Rissanen
, Hannele Ylipahkala
, et al.
·
Journal of Bone and Mineral Metabolism
·
19
Models and screening assays for drug discovery in osteoporosis
2010
·
Jukka P Rissanen
, Jussi M Halleen
·
Expert Opinion on Drug Discovery
·
18
Additive Benefits of Radium-223 Dichloride and Bortezomib Combination in a Systemic Multiple Myeloma Mouse Model
2021
·
Mari I. Suominen
, Jenni Mäki-Jouppila
, et al.
·
International Journal of Molecular Sciences
·
6
PDF
Abstract 591: A novel high energy alpha-pharmaceutical: In vitro and in vivo potency of a mesothelin-targeted thorium-227 conjugate (TTC) in a model of bone disease
2016
·
Urs B. Hagemann
, Else-Marie Hagelin
, et al.
·
Cancer Research
·
6
Abstract 5712: Alpharadin (Radium-223 chloride) completely prevents tumor growth in bone and increases survival in a mouse model of breast cancer bone metastases in preventive and micro-metastatic settings
2012
·
Mari I. Suominen
, Jukka P. Rissanen
, et al.
·
Cancer Research
·
5
Markers of Bone Turnover in Preclinical Development of Drugs for Skeletal Diseases
2013
·
Jukka P. Rissanen
·
UTUPub (University of Turku)
·
4
PDF
The anti-tumor agent sagopilone shows antiresorptive effects both in vitro and in vivo
2010
·
A. Strube
, M. I. Suominen
, et al.
·
Osteoporosis International
·
4
Abstract 786: Effects of combination treatment with cabozantinib and bortezomib in the 5TGM1 murine multiple myeloma model
2015
·
Mari I. Suominen
, Katja M. Fagerlund
, et al.
·
Cancer Research
·
3
Abstract 1803: A new spectrum-selective cathepsin inhibitor, VBY-825, inhibits bone destruction in a syngeneic 5TGM1 multiple myeloma mouse model
2014
·
Mari I. Suominen
, Johanna Tuomela
, et al.
·
Cancer Research
·
3
Abstract 49: Comparison of subcutaneous and orthotopic tumor growth in syngeneic mouse models of ovarian and renal cancer
2023
·
Mari I. Suominen
, Justyna Zdrojewska
, et al.
·
Cancer Research
·
2
Abstract 5202: Additive benefits of radium-223 dichloride and bortezomib combination in a syngeneic 5TGM1 multiple myeloma mouse model
2017
·
Mari I. Suominen
, Jukka P. Rissanen
, et al.
·
Cancer Research
·
2
Differences in the effects of intra-articular treatment with recombinant human bone morphogenetic protein 7 (BMP-7) on the development of osteoarthritis between surgically induced rat models
2016
·
J. Morko
, Z. Peng
, et al.
·
Osteoarthritis and Cartilage
·
2
Intra-articular treatment with recombinant human bone morphogenetic protein 7 (BMP-7) attenuates the development of osteoarthritis in a surgically induced rat model
2014
·
J. Morko
, Z. Peng
, et al.
·
Osteoarthritis and Cartilage
·
2
PDF
Abstract 3318: PSMA-targeted thorium-227 conjugate (PSMA-TTC) inhibits tumor growth and abnormal bone changes in the intratibial LNCaP xenograft model of bone-metastatic prostate cancer
2022
·
Christoph Schatz
, Mari I. Suominen
, et al.
·
Cancer Research
·
1
Abstract 1624: Immune cell killing assay for measuring the effects of immunomodulating agents in lung cancer cells in vitro
2022
·
Jenni H. Mäki-Jouppila
, Jukka P. Rissanen
, et al.
·
Cancer Research
·
1
Abstract 3447: Radium-223 dichloride exhibits dual mode-of-action inhibiting both tumor and tumor-induced bone growth in two osteoblastic prostate cancer models
2015
·
Mari I. Suominen
, Katja M. Fagerlund
, et al.
·
Cancer Research
·
1
Abstract LB-105: Radium-223 dichloride monotherapy and combination therapy with zoledronic acid or doxorubicin improve survival in a mouse model of breast cancer bone metastasis.
2013
·
Mari I. Suominen
, Jukka P. Rissanen
, et al.
·
Cancer Research
·
1
Show more works
View as search
Works count:
70
Citation count:
775
H-index:
10
I10-index:
10
Year
Topic
Type